Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review

Introduction: The severity of COVID-19 may be correlated with the risk of liver injury development. An increasing number of studies indicate that degrees of hepatotoxicity has been associated with using some medications in the management of COVID-19 patients. However, limited studies had systematica...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Frontiers in medicine Ročník 8; s. 731436
Hlavní autoři:	Sodeifian, Fatemeh, Seyedalhosseini, Zahra Sadat, Kian, Naghmeh, Eftekhari, Mahya, Najari, Shaghayegh, Mirsaeidi, Mehdi, Farsi, Yeganeh, Nasiri, Mohammad Javad
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland Frontiers Media SA 20.09.2021 Frontiers Media S.A
Témata:	adverse drug reaction Antibiotics Case reports Cohort analysis COVID-19 Cross-sectional studies Disease drug induced liver injury (DILI) Fever Liver liver injury Medicine Pathogenesis Patients Pneumonia SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Side effects Systematic review Viral infections Italy Netherlands United States > US China Japan COVID-19 SARS-CoV-2 liver injury drug induced liver injury (DILI) adverse drug reaction
ISSN:	2296-858X, 2296-858X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!